School of Medicine
Showing 21-40 of 89 Results
-
Ellen Markman
IBM Provostial Professor
BioMarkman’s research interests include the relationship between language and thought; early word learning; categorization and induction; theory of mind and pragmatics; implicit theories and conceptual change, and how theory-based explanations can be effective interventions in health domains.
-
Jessie Markovits, MD
Clinical Associate Professor, Medicine
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsHypnosis for perioperative symptom management in elective orthopedic surgery.
-
Alison Marsden
Douglass M. and Nola Leishman Professor of Cardiovascular Diseases, Professor of Pediatrics (Cardiology) and of Bioengineering and, by courtesy, of Mechanical Engineering
Current Research and Scholarly InterestsThe Cardiovascular Biomechanics Computation Lab at Stanford develops novel computational methods for the study of cardiovascular disease progression, surgical methods, and medical devices. We have a particular interest in pediatric cardiology, and use virtual surgery to design novel surgical concepts for children born with heart defects.
-
Nicole Martinez-Martin
Assistant Professor (Research) of Pediatrics (Biomedical Ethics) and, by courtesy, of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsNIH/National Institute of Mental Health
K01 MH118375-01A1
“Ethical, Legal and Social Implications in the Use of Digital Technology for Mental Health Applications”
Greenwall Foundation Making a Difference in Bioethics Grant
“Ethical, Legal and Social Implications of Digital Phenotyping” -
Olivia Martinez
Johnson and Johnson Professor of Surgery
Current Research and Scholarly InterestsHost-Pathogen interactions; EBV B cell lymphomas; pathways of immune evasion in the growth and survival of EBV B cell lymphomas; mechanisms of graft rejection and tolerance induction; stem cell and solid organ transplantation.
-
Daphne O. Martschenko
Assistant Professor (Research) of Pediatrics (Stanford Center for Biomedical Ethics)
BioDr. Daphne Oluwaseun Martschenko is an Assistant Professor at the Laurie J. Girand Center for Biomedical Ethics at Stanford. Her scholarship identifies novel ways to examine and enhance the ethical and socially responsible conduct, translation, and interpretation of human genetic research.
Dr. Martschenko is passionate about fostering public and community engagement with controversial scientific research. She has appeared in the New York Times and on numerous podcasts including Freakonomics Radio. Dr. Martschenko’s work is published in publicly accessible media outlets such as Scientific American and The Conversation. In 2023, she was named one of 10 Scientists to Watch by ScienceNews.
Dr. Martschenko is author of the book What We Inherit: How New Technologies and Old Myths Are Shaping Our Genomic Future, which she wrote with friend and colleague Sam Trejo, a sociologist at Princeton University. Over the past decade, the field of human genetics has rapidly produced a wide range of never-before-seen genomic tools; together, they debate and discuss a range of social, ethical, and policy issues raised by this so-called DNA revolution. Though there’s plenty the two disagree about, they share a firm belief that—in order to successfully navigate the transition to a society where genetic prediction is increasingly accurate and available—it is vital that society take seriously the impact both of DNA and of pernicious genetic myths. -
Brittany Elizabeth Matheson, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical associate professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Maya Mathur
Associate Professor (Research) of Pediatrics, of Medicine (Computational Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases
-
Mohamad Matout, MD, MSc
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mohamad Matout is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Matout specializes in using brain stimulation therapies to treat mental illnesses and neurological disorders that do not respond to standard treatments. These therapies include deep brain stimulation (DBS), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). He serves as the attending psychiatrist for the Youth TMS Clinic at Stanford Health Care, providing transcranial magnetic stimulation for adolescents with treatment-resistant mood disorders. Dr. Matout also uses avatar therapy, an investigational treatment for psychosis that involves using a digital avatar to represent the voices a patient hears.
Dr. Matout’s research centers on brain health as a unifying framework for understanding psychiatric illness across the lifespan. Using a statistical modeling technique called psychometric network analysis, he maps how psychiatric symptoms mutually reinforce or suppress one another. This method reveals the structure of mental illness beyond traditional diagnostic categories. Dr. Matout developed the approach through his graduate work on brain health in HIV and post-COVID syndrome. He now applies it to neuromodulation (changing nerve signals for treatment) and other novel interventions.
Dr. Matout’s two primary lines of research are TMS for adolescents and avatar therapy. He also contributes to a broader range of neuromodulation studies through collaboration with the Brain Stimulation Lab at Stanford University School of Medicine. Beyond his clinical and research work, Dr. Matout is co-founder of AVAtalk Technologies Inc., a mental health technology startup focused on avatar-based therapeutic solutions.
Dr. Matout has authored peer-reviewed publications in Social Psychiatry and Psychiatric Epidemiology, Quality of Life Research, and CEN Case Reports. He has also contributed chapters to Current Medical Diagnosis & Treatment 2027 and Katzung & Trevor's Basic & Clinical Pharmacology (17th ed., McGraw-Hill, in press).
Dr. Matout is a member of the American Neuropsychiatric Association (ANPA) and the Brain Stimulation Society (BraSS), where he serves as assistant treasurer. -
Sean McGhee
Clinical Professor, Pediatrics - Immunology
Current Research and Scholarly InterestsBioinformatics
-
Safyer McKenzie-Sampson
Member, Maternal & Child Health Research Institute (MCHRI)
BioSafyer McKenzie-Sampson is an IDEAL Provostial Fellow and instructor within the Department of Pediatrics at Stanford University. Dr. McKenzie-Sampson is a social and perinatal epidemiologist, focused on researching the multi-level impacts of exposure to racism across the life course on the risk of adverse perinatal outcomes in Black communities, with the goal of translating findings into interventions to increase birth justice. Her research portfolio uniquely interrogates the rates of adverse perinatal outcomes through the lens of maternal nativity in the United States which allows for focus on the experiences of Black immigrants. She is currently the principal investigator of the AZANIA study, a mixed methods pilot study which collects data on the pregnancy and childbirth experiences of African immigrants in California. Dr. McKenzie-Sampson received her PhD in Epidemiology and Translational Science from the University of California San Francisco, and in addition to her research, she supports families in the Bay Area as a full-spectrum community doula.
-
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Jennifer A McNab
Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)
Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.
